Erratum: Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population (Eye (2015) 29 (272-279) DOI: 10.1038/eye.2014.260);Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population

Eye (Basingstoke)

Volumn 29, Issue 2, 2015, Pages 272-279

  Diniz, B ^a,b   Rodger, D C ^a,c   Chavali, V R ^d   Mackay, T ^d   Lee, S Y ^a,c   Stambolian, D ^d   Sadda, S V R ^a,c  

^a DOHENY EYE INSTITUTE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; ATROPHY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DRUSEN; FEMALE; GEOGRAPHIC ATROPHY; GERIATRIC PATIENT; HUMAN; IMAGING SOFTWARE; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; RETINA DISEASE; RETINA FOVEA; RETINA MACULA LUTEA; RETINAL PIGMENT EPITHELIUM ATROPHY; SEX RATIO; SMOKING; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; AGING; ALGORITHM; BLOOD PRESSURE; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM;

AGED; AGED, 80 AND OVER; AGING; ALGORITHMS; ATROPHY; BLOOD PRESSURE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; RETINAL DRUSEN; RETINAL PIGMENT EPITHELIUM; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84938398353     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.307     Document Type: Erratum

References (42)

1. Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA 2004; 291: 1900-1901
2. Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol 2003; 121: 658-663
3. Butt AL, Lee ET, Klein R, Russell D, Ogola G, Warn A et al. Prevalence and risks factors of age-related macular degeneration in Oklahoma Indians: the Vision Keepers Study. Ophthalmology 2011; 118: 1380-1385
4. Abdelsalam A, Del Priore L, Zarbin MA. Drusen in age-related macular degeneration: pathogenesis, natural course, and laser photocoagulation-induced regression. Surv Ophthalmol 1999; 44: 1-29
5. Fleckenstein M, Adrion C, Schmitz-Valckenberg S, Göbel AP, Bindewald-Wittich A, Scholl H et al. Concordance of disease progression in bilateral geographic atrophy due to AMD. Invest Ophthalmol Vis Sci 2010; 5: 637-642
6. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration. Mol Vis 1999; 5: 25
7. Strahlman ER, Fine SL, Hillis A. The second eye of patients with senile macular degeneration. Arch Ophthalmol 1983; 101: 1191-1193
8. Roy M, Kaiser-Kupfer M. Second eye involvement in age-related macular degeneration: a four-year prospective study. Eye 1990; 4: 813-818
9. Wang JJ, Mitchell P, Smith W, Cumming RG. Bilateral involvement by age related maculopathy lesions in a population. Br J Ophthalmol 1998; 82: 743-747
10. Coffey AJ, Brownstein S. The prevalence of macular drusen in postmortem eyes. Am J Ophthalmol 1986; 102: 164-171
11. Yehoshua Z, Rosenfeld PJ, Gregori G, Penha F. Spectral domain optical coherence tomography imaging of dry age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2010; 41(Suppl): S6-14
12. Fleckenstein M, Schmitz-Valckenberg S, Adrion C, Visvalingam S, Göbel AP, Mössner A et al. Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci 2011; 52: 6552-6557
13. Gregori G, Wang F, Rosenfeld PJ, Yehoshua Z, Gregori NZ, Lujan BJ et al. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology 2011; 118: 1373-1379
14. Chiu SJ, Izatt JA, O'Connell RV,Winter KP, Toth CA, Farsiu S. Validated automatic segmentation of AMD pathology including drusen and geographic atrophy in SD-OCT images. Invest Ophthalmol Vis Sci 2012; 53: 53-61
15. Nittala M, Ruiz-Garcia H, Sadda SR. Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2012; 53: 8319-8324
16. Yehoshua Z, Garcia Filho CA, Penha FM, Gregori G, Stetson PF, Feuer WJ et al. Comparison of geographic atrophy measurements from the OCT fundus image and the sub-RPE slab image. Ophthalmic Surg Lasers Imaging Retina 2013; 44: 127-32
17. Yehoshua Z, Wang F, Rosenfeld P, Penha FM, Feuer WJ, Gregori G. Natural history of drusen morphology in agerelated macular degeneration using spectral domain optical coherence tomography. Ophthalmology 2011; 118: 2434-2441
18. Sallo FB, Rechtman E, Peto T, Stanescu-Segall D, Vogt G, Bird AC et al. Functional aspects of drusen regression in age-related macular degeneration. Br J Ophthalmol 2009; 93: 1345-1350
19. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 1973; 90: 206-217
20. Rudnicka AR, Jarrar Z, Wormald R, Penha FM, Feuer WJ, Gregori G. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012; 119(3): 571-580
21. Klein R, Klein BEK, Knudtson MD, Wong TY, Cotch MF, Liu K et al. Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology 2006; 113: 373-380
22. The Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992; 110: 1701-1708
23. Klein R, Klein BEK, Linton KLP, DeMets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 1993; 137: 190-200
24. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276: 1141-1146
25. Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996; 276: 1147-1151
26. Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol 1979; 11: 1197-1201
27. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986; 93: 552-558
28. West SK, Rosenthal FS, Bressler NM, Bressler SB, Munoz B, Fine SL et al. Exposure to sunlight and other risk factors for age-related macular degeneration. Arch Ophthalmol 1989; 107: 875-879
29. Klein R, Klein BE, Moss SE. Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 1998; 147: 103-110
30. McCarty CA, Mukesh BN, Fu CL, Mitchell P, Wang JJ, Taylor HR. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 2001; 119: 1455-1462
31. Khan JC, Thurlby DA, Shahid H, Clayton DG, Yates JR, Bradley M et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol 2006; 90: 75-80
32. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: a review of association. Eye 2005; 19: 935-944
33. Klein R, Klein BE, Tomany SC, Cruickshanks KJ. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 2003; 110: 636-643
34. Choudhury F, Varma R, McKean-Cowdin R, Klein R, Azen SP. Los Angeles Latino Eye Study Group. Risk factors for four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study. Am J Ophthalmol 2011; 152: 385-395
35. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA et al. The Framingham Eye Study monograph; an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration. Surv Ophthalmol 1980; 24: 335-610
36. Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology 1999; 106: 1768-1779
37. Bellmann C, Jorzik J, Spital G, Unnebrink K, Pauleikhoff D, Holz FG. Symmetry of bilateral lesions in geographic atrophy in patients with age-related macular degeneration. Arch Ophthalmol 2002; 120: 579-584
38. Coffey AJH, Brownstein S. The prevalence of macular drusen in postmortem eyes. Am J Ophthalmol 1986; 102: 164-171
39. Barondes M, Pauleikhoff D, Chisholm IC, Minassian D, Bird AC. Bilaterality of drusen. Br J Ophthalmol 1990; 74: 180-182
40. Jain N, Farsiu S, Khanifar A, Bearelly S, Smith RT, Izatt JA et al. Quantitative comparison of drusen segmented on SD OCT versus drusen delineated on color fundus photographs. Invest Ophthalmol Vis Sci 2012; 51: 4875-4883
41. Yehoshua Z, Rosenfeld PJ, Gregori G, Feuer WJ, Falcao M, Lujan BJ et al. Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology 2011; 118: 679-686
42. Schlanitz FG, Baumann B, Spalek T, Schü tze C, Ahlers C, Pircher M et al. Performance of automated drusen detection by polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci 2011; 52: 4571-4579.